NDC product
Mycophenolic Acid
NDC 82293-013 · Novugen Pharma (USA) LLC.
Key facts
| Product NDC | 82293-013 |
|---|---|
| Proprietary name | Mycophenolic Acid |
| Nonproprietary name | Mycophenolic Acid |
| Substances | MYCOPHENOLATE SODIUM |
| Dosage form | TABLET, DELAYED RELEASE |
| Route | ORAL |
| Labeler | Novugen Pharma (USA) LLC. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA216637 |
| Pharmacologic classes | Antimetabolite Immunosuppressant [EPC] |
| Marketing start | Sep 1, 2024 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: